15.06.2017
- Canada-based, US-run drugmaker Valeant has agreed to sell its iNova Pharmaceuticals subsidiary for $930 million in cash to a company jointly owned by funds advised and managed by...
13.04.2016
- The US Senate’s Special Committee on Aging plans to decide on Apr. 13 whether or not to open contempt proceedings against Valeant Pharmaceuticals CEO Michael Pearson. Pearson, who...
03.03.2016
- Canada-based, US-managed drug firm Valeant Pharmaceuticals has confirmed it is under another investigation by the Securities and Exchange Commission (SEC), the latest in a string...
03.11.2015
- Canadian drugmaker Valeant has said it will sever ties with Philidor, the specialty pharmacy it has been accused of using to falsify sales and drive selling prices. The company’s...
04.09.2012
- Valeant Pharmaceuticals International agreed on Monday to buy Medicis Pharmaceutical for $2.6 billion in cash, in a deal that will add Botox competitor Dysport and other skin care...
30.01.2012
- Valeant Pharmaceuticals International said on Monday it has withdrawn its sweetened takeover bid for ISTA Pharmaceuticals, citing a lack of progress. "We were not interested in...
04.05.2011
- Valeant Pharmaceuticals, which dropped a $5.7 billion offer for Cephalon earlier this week, will actively pursue other large takeover deals, its chief executive said on Tuesday...
